Affiliation:
1. South Ural State Medical University
2. Peoples’ Friendship University of Russia
Abstract
Introduction. In the complex therapy of acute bacterial sinusitis, drugs that have antibacterial, anti-inflammatory, mucolytic effects are widely used. The article discusses the effectiveness of the use of a phytopreparation containing standardized myrtol, limonene, cineol and alpha – pinene in the treatment of acute sinusitis in patients who have undergone SARS-CoV-2.Aim. To increase the effectiveness of conservative therapy of acute bacterial sinusitis in people who have undergone a new coronavirus infection (SARS-CoV-2) using a complex phytopreparation.Materials and methods. A simple randomized controlled clinical research study involved 83 patients suffering from acute bacterial sinusitis after a coronavirus infection. Potential, safety and recovery time were evaluated in two groups: a group of patients (n = 41) taking standardized Myrtol limonel, cineol and alpha – pinene (a phytotherapeutic drug), compared with a group (n = 42) taking an antibacterial drug. The severity of clinical manifestations was assessed according to the VAS scale, cognitive functions and memory were carried out using standard psychological tests and an assessment of the quality of life according to SNOT-22.Results and discussion. The use of Respero Myrtol forte, containing standardized Myrtol limonel, cineol and alpha-pinene, in the complex therapy of bacterial sinusitis in people who have undergone a new coronavirus infection (SARS-CoV-2) has significantly improved clinical symptoms, cognitive functions and the quality of life. Good drug tolerance, high potential and safety, recovery and improvement of the quality of life at an early date were noted.Conclusions. In the treatment of patients with bacterial sinusitis in people who have undergone a new coronavirus infection (SARS-CoV-2), Respiro Myrtol forte has shown high antibacterial, anti-inflammatory and mucolytic effects, good bioavailability, tolerance and safety.
Reference59 articles.
1. Karneeva O.V., Gurov A.V., Karpova E.P., Tulupov D.A., Ryazantsev S.V., Garashchenko T.I. et al. Acute sinusitis: clinical guidelines. National Medical Association of Otorhinolaryngologists. Moscow; 2021. Available at: https://cr.minzdrav.gov.ru/recomend/313_2.
2. Lopatin A.S., Shilenkova V.V. (eds.). Acute sinusitis: clinical guidelines. Russian Society of Rhinologists. Moscow; 2021. Available at: http://rhinology.ru/2021/09/15/obnovlennye-klinicheskie-rekomendacii-rossijskogo-obshhestva-rinologov-ostryj-rinosinusit.
3. Chow A.W., Benninger M.S., Brook I., Brozek J.L., Goldstein E.J., Hicks L.A. et al.; Infectious Diseases Society of America. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012;54(8):e72-e112. https://doi.org/10.1093/cid/cir1043.
4. Korkmazov M.Yu., Kornova N.V., Chin’kov N.A. The nature of cephalgia in acute and chronic sinusitis, their impact on the quality of life. Rossiyskaya Otorinolaringologiya. 2009;(2):96–101. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=14565167.
5. Patel G.B., Kern R.C., Bernstein J.A., Hae-Sim P., Peters A.T. Current and Future Treatments of Rhinitis and Sinusitis. J Allergy Clin Immunol Pract. 2020;8(5):1522–1531. https://doi.org/10.1016/j.jaip.2020.01.031.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献